SG10201506686WA - Conjugates - Google Patents
ConjugatesInfo
- Publication number
- SG10201506686WA SG10201506686WA SG10201506686WA SG10201506686WA SG10201506686WA SG 10201506686W A SG10201506686W A SG 10201506686WA SG 10201506686W A SG10201506686W A SG 10201506686WA SG 10201506686W A SG10201506686W A SG 10201506686WA SG 10201506686W A SG10201506686W A SG 10201506686WA
- Authority
- SG
- Singapore
- Prior art keywords
- conjugates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201506686WA SG10201506686WA (en) | 2015-08-24 | 2015-08-24 | Conjugates |
US15/754,573 US20180250403A1 (en) | 2015-08-24 | 2016-08-24 | Conjugates |
PCT/SG2016/050409 WO2017034482A2 (en) | 2015-08-24 | 2016-08-24 | Conjugates |
CN201680060017.3A CN108136018A (en) | 2015-08-24 | 2016-08-24 | conjugate |
EP16839718.0A EP3341022A4 (en) | 2015-08-24 | 2016-08-24 | Conjugates |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201506686WA SG10201506686WA (en) | 2015-08-24 | 2015-08-24 | Conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201506686WA true SG10201506686WA (en) | 2017-03-30 |
Family
ID=58100692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201506686WA SG10201506686WA (en) | 2015-08-24 | 2015-08-24 | Conjugates |
Country Status (5)
Country | Link |
---|---|
US (1) | US20180250403A1 (en) |
EP (1) | EP3341022A4 (en) |
CN (1) | CN108136018A (en) |
SG (1) | SG10201506686WA (en) |
WO (1) | WO2017034482A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201710097D0 (en) * | 2017-06-23 | 2017-08-09 | Univ Ulster | A sensitizer - peptide conjugate |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL102645A (en) * | 1992-07-26 | 1998-02-22 | Yeda Res & Dev | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
US6147195A (en) * | 1993-07-26 | 2000-11-14 | Yeda Research And Development Co., Ltd. | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
US20050209331A1 (en) * | 2004-03-22 | 2005-09-22 | Syneron Medical Ltd. | Method of treatment of skin |
US20060052286A1 (en) * | 2004-08-13 | 2006-03-09 | Yale University | Factor VII conjugates for selectively treating neovascularization disorders |
GB0520436D0 (en) * | 2005-10-07 | 2005-11-16 | Photobiotics Ltd | Biological materials and uses thereof |
ES2763237T3 (en) * | 2006-08-23 | 2020-05-27 | Yeda Res & Dev | Conjugates of RGD peptides and photosensitizers of (bacterio) chlorophyll and their uses |
WO2008039994A2 (en) * | 2006-09-28 | 2008-04-03 | The Trustees Of The University Of Pennsylvania | Targeted photodynamic therapy agent |
US8440793B2 (en) * | 2008-05-27 | 2013-05-14 | Genzyme Corporation | Peptide analogs of alpha-melanocyte stimulating hormone |
TWI442945B (en) * | 2011-05-18 | 2014-07-01 | Univ Nat Taiwan | Methods of using dual-effect liposome in therapy |
WO2014071457A1 (en) * | 2012-11-08 | 2014-05-15 | Newsouth Innovations Pty Limited | Dual action nitric oxide donors and their use as antimicrobial agents |
-
2015
- 2015-08-24 SG SG10201506686WA patent/SG10201506686WA/en unknown
-
2016
- 2016-08-24 US US15/754,573 patent/US20180250403A1/en not_active Abandoned
- 2016-08-24 CN CN201680060017.3A patent/CN108136018A/en active Pending
- 2016-08-24 WO PCT/SG2016/050409 patent/WO2017034482A2/en active Application Filing
- 2016-08-24 EP EP16839718.0A patent/EP3341022A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20180250403A1 (en) | 2018-09-06 |
WO2017034482A2 (en) | 2017-03-02 |
WO2017034482A3 (en) | 2017-04-06 |
EP3341022A2 (en) | 2018-07-04 |
EP3341022A4 (en) | 2019-07-17 |
CN108136018A (en) | 2018-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL285516B (en) | Amatoxin-antibody conjugates | |
ZA201904269B (en) | Pyrrolobenzodiazepine-antibody conjugates | |
ZA201704297B (en) | Pyrrolobenzodiazepine-antibody conjugates | |
PT3119885T (en) | Antibody-fynomer conjugates | |
RS61795B1 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
GB201513607D0 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
GB201702031D0 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
GB201504694D0 (en) | Covalent conjugates | |
HK1257229A1 (en) | Cck2r-drug conjugates | |
PT3270711T (en) | Sugar-dipeptide conjugates | |
SG10201506686WA (en) | Conjugates | |
GB201721290D0 (en) | Conjugates | |
GB201719906D0 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
GB201719398D0 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
GB201719393D0 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
GB201719391D0 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
GB201706466D0 (en) | pyrrolobenzodiazepine-peptide conjugates | |
GB201518839D0 (en) | Conjugates | |
GB201702029D0 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
GB201513605D0 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
GB201517852D0 (en) | Novel compounds and conjugates | |
GB201420910D0 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
GB201406718D0 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
GB201406719D0 (en) | Pyrrolobenzodiaepine-antibody conjugates | |
GB201406720D0 (en) | Pyrrolobenzodiazepine-antibody conjugates |